Wednesday, June 19, 2013 Last update: 6:48 AM
Company Tech News as it Breaks
Trade Events
VIVUS, Inc.
News articles for VIVUS, Inc.:
Tuesday, April 16, 2013
- VIVUS Announces FDA Approval of Qsymia REMS Modification Allowing Access Through Certified Retail PharmaciesMOUNTAIN VIEW, Calif., April 16, 2013 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved its amendment and modification to the Risk Evaluation and Mitigation Strategy (REMS) for Qsymia(® )(phentermine and topiramate extended-release) capsules CIV. The amendment, ... read more
Wednesday, April 10, 2013
- New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual MeetingMOUNTAIN VIEW, Calif., April 10, 2013 /PRNewswire/ -- A new educational program, Excess Weight and Your Health: A Guide to Effective, Healthy Weight Loss, developed by the Obesity Action Coalition (OAC) and the American College of Physicians (ACP), will be released today at Internal Medicine 2013, ... read moreNew Obesity Education Program To Premiere At American College of Physicians (ACP) Annual MeetingMOUNTAIN VIEW, Calif., April 10, 2013 /PRNewswire/ -- A new educational program, Excess Weight and Your Health: A Guide to Effective, Healthy Weight Loss, developed by the Obesity Action Coalition (OAC) and the American College of Physicians (ACP), will be released today at Internal Medicine 2013, ... read more
Monday, March 25, 2013
- Analysis In Health Economics Review Concludes Effective Medical Obesity Treatment Could Reduce Medicare SpendingMOUNTAIN VIEW, Calif., March 25, 2013 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight loss could lead to significant improvements in Medicare spending by reversing or reducing significant health consequences such ... read more
Thursday, March 7, 2013
- VIVUS Launches Mobile App to Help Patients Lose WeightMOUNTAIN VIEW, Calif., March 7, 2013 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) announced today the launch of the Q and Me(TM) app, a no-cost mobile app available through iTunes and Google Play Store designed to help patients meet their weight loss goals. Q and Me can be used by ... read more
Tuesday, March 5, 2013
- VIVUS Announces New Qsymia OfferMOUNTAIN VIEW, Calif., March 5, 2013 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced a new program offering eligible patients a discount on Qsymia(®) (phentermine and topiramate extended-release) capsules CIV for a limited time. The Save Now! Program is available online exclusively at www.qsymia.com ... read more
Friday, February 1, 2013
- Study Concludes That Weight Loss With Qsymia(TM) Significantly Improves Multiple Cardiovascular Disease Risk FactorsMOUNTAIN VIEW, Calif., Feb. 1, 2013 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) announced today the publication of a study concluding that weight loss resulting from treatment with Qsymia(TM) (phentermine and topiramate extended-release) capsules CIV led to significant improvements in cholesterol, blood pressure and triglycerides in obese and ... read more